Fig. 2From: Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulationRetinal electromagnetic stimulator (rEMS) device. Application of the helmet to stimulate the retina-optic nerve and visual pathways [35,36,37]Back to article page